Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Magnetic imaging agent
Patent
1985-10-11
1990-07-03
Rosen, Sam
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Magnetic imaging agent
424 4, 424 858, 4351722, 435948, 935102, 935107, 935808, 530387, 530402, 530808, A61K 4902, A61K 4900
Patent
active
049389483
ABSTRACT:
Hybridomas producing monoclonal antibodies suitable for imaging and diagnosis of human breast tumors and such monoclonal antibodies are claimed. The monoclonals are characterized by breast tumor binding range, breast cancer cell line range, and selectivity.
Immunoimaging agents comprising the monoclonal antibody and a detectable label, either directly or indirectly conjugated to the antibody are claimed. Methods for imaging breast tumors using the immunoimaging agents are described and claimed.
REFERENCES:
patent: 4522918 (1985-06-01), Schlom et al.
patent: 4695538 (1987-09-01), Cote et al.
patent: 4707438 (1987-11-01), Keydar
patent: 4753894 (1988-06-01), Frankel et al.
Colcher et al.--Chem. Abst. vol. 101 (1984) p. 168715q.
Neville et al.--Chem. Abst. vol. 101 (1984) p. 157653s.
Brabon et al.--Chem. Abst. vol. 101 (1984) p. 21734m.
Colcher, D. et al., Proc. Natl. Acad. Sci., vol. 78, pp. 3199-3203 (1981).
Yuan D., et al., JNCL., vol. 68, (1982).
Ciocca, D. R., et al., Cancer Research, vol. 42, pp. 4256-4258 (1982).
Kohler and Milstein, Nature vol. 256, pp. 495-497 (1975).
Buck, D. W., et al., In Vitro, vol. 18, pp. 377-381 (1982).
Wood, F. T., et al., Analytical Biochemistry, vol. 69, pp. 339-349 (1975).
Goodwin, D. A. et al., J. Nucl. Med., 26:493-503, (1985).
Meares, C. F., et al., Analytical Biochemistry, vol. 142, pp. 68-78 (1984).
Levine, G., et al., The Journal of Nuclear Medicine, vol. 21, pp. 570-573 (1980).
Ferrands, P. A., et al., The Lancet, (1982).
Zimmer, A. M., et al., Hybridoma, vol. 4, pp. 1-11, (1985).
Contreras, M. A., et al., Methods in Enzymology, vol. 92, pp. 277-292 (1983).
Khaw, B. A., et al., Hybridoma, vol. 3, pp. 11-23 (1984).
Krejcarek, G. E., et al., Biochemical and Biophysical Research Communications, vol. 77, pp. 581-585 (1977).
Hnatowich, D. J., et al., Science, vol. 220, pp. 613-615 (1983).
Scheinberg, D. A., et al., Science, vol. 215, pp. 1511-1513 (1982).
Thompson, C. H., et al., The Lancet, pp. 1245-1247 (1984).
Mach, J. P., et al., Cancer Research, vol. 43, pp. 5593-5600, (1983).
Murray, J. L., et al., Cancer Research, vol. 45, pp. 2376-2381, (1985).
Rosenblum, M. G., et al., Cancer Research, vol. 45, pp. 2382-2386, (1985).
Halpern, S. E., et al., Cancer Research, vol. 43, pp. 5347-5355, (1983).
Hnatowich, D. J., 1984 Abstract Form for Scientific Papers & Scientific Exhibits Society of Nuclear Medicine 31st Annual Meeting, Los Angeles, CA, Jun. 5-8-, 1984.
Burchell, J. et al., The Journal of Immunology, vol. 131, pp. 508-513 (1983).
Frankel Arthur E.
Ring David B.
Cetus Corporation
Fineman Elliott E.
Giotta Gregory J.
Halluin Albert P.
Rosen Sam
LandOfFree
Method for imaging breast tumors using labeled monoclonal anti-h does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for imaging breast tumors using labeled monoclonal anti-h, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for imaging breast tumors using labeled monoclonal anti-h will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1889533